Form 4 for BDSX BIODESIX INC
Accepted 2023-08-07 00:00:00 ET · period of report 2023-08-03 · accession 0000905148-23-000625 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-07 | 2023-08-03 | BDSX | O'Kane Kieran | Chief Commercial Off | A - Grant | $1.62 | +6,172 | 42.9K | +17% | +$9,999 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-03 | A | A | 6,172 | $1.62 | 42,929 | D | — | — |